These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 28299661
21. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells. Miller JD, Stacy T, Liu PP, Speck NA. Blood; 2001 Apr 15; 97(8):2248-56. PubMed ID: 11290585 [Abstract] [Full Text] [Related]
25. Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report. Zhang W, Wang H, Zhang P, Li H, Ma X, Liu H. Braz J Med Biol Res; 2021 Apr 15; 54(12):e11605. PubMed ID: 34730684 [Abstract] [Full Text] [Related]
28. RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia. Wang S, Liu Y, Zhao X, Wang X, Lou J, Jin P, Zhang Y, Yu J, Wang K. Br J Haematol; 2024 Aug 17; 205(2):552-567. PubMed ID: 38802066 [Abstract] [Full Text] [Related]
29. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal. Zhao X, Chen A, Yan X, Zhang Y, He F, Hayashi Y, Dong Y, Rao Y, Li B, Conway RM, Maiques-Diaz A, Elf SE, Huang N, Zuber J, Xiao Z, Tse W, Tenen DG, Wang Q, Chen W, Mulloy JC, Nimer SD, Huang G. Blood; 2014 Mar 13; 123(11):1729-38. PubMed ID: 24449215 [Abstract] [Full Text] [Related]
30. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia. Fischer J, Rossetti S, Datta A, Eng K, Beghini A, Sacchi N. Mol Cancer; 2015 Jan 23; 14():7. PubMed ID: 25612891 [Abstract] [Full Text] [Related]
33. Acute myeloid leukemia with cryptic CBFB-MYH11 type D. Kobayashi T, Ichikawa M, Kamikubo Y, Kurokawa M. Int J Clin Exp Pathol; 2013 Jan 23; 6(1):110-2. PubMed ID: 23236551 [Abstract] [Full Text] [Related]
34. CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16). Helbling D, Mueller BU, Timchenko NA, Schardt J, Eyer M, Betts DR, Jotterand M, Meyer-Monard S, Fey MF, Pabst T. Blood; 2005 Aug 15; 106(4):1369-75. PubMed ID: 15855281 [Abstract] [Full Text] [Related]
35. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22). Kurata K, Yamamoto K, Okazaki Y, Noguchi Y, Matsui K, Matsumoto H, Inui Y, Yakushijin K, Ito M, Nakamachi Y, Matsuoka H, Saegusa J, Minami H. Cancer Genet; 2020 Feb 15; 241():72-76. PubMed ID: 31353165 [Abstract] [Full Text] [Related]
37. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia. Clarke S, de Kraa R, Chuah H, Creeper K, Leahy MF, Wright M. Cancer Genet; 2022 Aug 15; 266-267():7-14. PubMed ID: 35613501 [Abstract] [Full Text] [Related]
38. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Adya N, Stacy T, Speck NA, Liu PP. Mol Cell Biol; 1998 Dec 15; 18(12):7432-43. PubMed ID: 9819429 [Abstract] [Full Text] [Related]
39. Synchronous Diagnosis of De Novo Acute Myeloid Leukemia with inv(16)(p13q22) and Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature. Shoyele O, Gupta G. Ann Clin Lab Sci; 2018 Nov 15; 48(6):790-796. PubMed ID: 30610052 [Abstract] [Full Text] [Related]
40. CBFβ-SMMHC Affects Genome-wide Polycomb Repressive Complex 1 Activity in Acute Myeloid Leukemia. Cordonnier G, Mandoli A, Cagnard N, Hypolite G, Lhermitte L, Verhoeyen E, Asnafi V, Dillon N, Macintyre E, Martens JHA, Bond J. Cell Rep; 2020 Jan 14; 30(2):299-307.e3. PubMed ID: 31940477 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]